Archives
Opinion | “’It’s a very special picture.’ Why vaccine safety experts put the brakes on AstraZeneca’s COVID-19 vaccine”
18 Mar, 2021 | 09:14h | UTC‘It’s a very special picture.’ Why vaccine safety experts put the brakes on AstraZeneca’s COVID-19 vaccine – Science (a few articles per month are free)
Related: Update on the safety of COVID-19 Vaccine AstraZeneca (statement and commentaries)
WHO Statement | The benefits of the AstraZeneca vaccine outweigh its risks – vaccinations should continue
18 Mar, 2021 | 09:17h | UTCWHO statement on AstraZeneca COVID-19 vaccine safety signals – World Health Organization
Related: Update on the safety of COVID-19 Vaccine AstraZeneca (statement and commentaries)
Commentary on Twitter (thread – click for more)
At this time, WHO considers that the benefits of the AstraZeneca vaccine outweigh its risks and recommends that vaccinations continue.
Full statement on AstraZeneca #COVID19 vaccine safety signals:
👉 https://t.co/9J6MtxXWK8 pic.twitter.com/fWGzqbjMuE— World Health Organization (WHO) (@WHO) March 17, 2021
Opinion | “The zero-risk mentality stifling Europe is now killing its people”
18 Mar, 2021 | 09:11h | UTCThe zero-risk mentality stifling Europe is now killing its people – The Sidney Morning Herald
Related: Update on the safety of COVID-19 Vaccine AstraZeneca (statement and commentaries)
Systematic Review: Thoracic imaging tests for the diagnosis of COVID‐19
18 Mar, 2021 | 09:05h | UTCThoracic imaging tests for the diagnosis of COVID‐19 – Cochrane Library
Opinion | “Oxford-AstraZeneca Vaccine Safety: Reports of blood clots after receiving the AstraZeneca COVID-19 vaccine are very likely just background events.”
18 Mar, 2021 | 09:09h | UTCRelated: Update on the safety of COVID-19 Vaccine AstraZeneca (statement and commentaries) AND What is Going on With the AstraZeneca/Oxford Vaccine? – Science Translational Medicine
Just How Do Deaths Due to COVID-19 Stack Up?
18 Mar, 2021 | 09:03h | UTCJust How Do Deaths Due to COVID-19 Stack Up? – Think Global Health
Commentary on Twitter (thread – click for more)
The Americas and Europe accounted for 80% of COVID-19 deaths globally, even though they represent only a quarter of the world's population. @ThinkGlobalHlth launches a tracker of COVID as a cause of death globally and the factors driving those trends 1/https://t.co/t6xp2yAWA4 pic.twitter.com/SJ9DRdlu1e
— Tom Bollyky (@TomBollyky) March 17, 2021
Long Covid | Four-month clinical status of a cohort of patients after hospitalization for COVID-19
18 Mar, 2021 | 09:00h | UTCFour-Month Clinical Status of a Cohort of Patients After Hospitalization for COVID-19 – JAMA
Editorial: Outcomes for Patients Following Hospitalization for COVID-19
Why Opening Windows Is a Key to Reopening Schools
18 Mar, 2021 | 09:02h | UTCWhy Opening Windows Is a Key to Reopening Schools – The New York Times (free registration may be required)
Commentary on Twitter
https://twitter.com/trishgreenhalgh/status/1372180956094865409
COVID-19 vaccines vs. variants—determining how much immunity is enough
18 Mar, 2021 | 08:58h | UTCCOVID-19 Vaccines vs Variants—Determining How Much Immunity Is Enough – JAMA
Population Study: Past Covid-19 confers 80.5% protection against reinfection, which decreases to 47.1% in those aged 65 years and older
18 Mar, 2021 | 09:06h | UTCCommentaries: Risk of SARS-CoV-2 reinfection after natural infection – The Lancet AND COVID-19 Reinfection: More Common Than We Think? – MedPage Today (free registration required)
Commentary on Twitter
NEW—Most people who have had original #COVID19 strain are protected from catching it again for at least 6 months—but those ≥65 years are more prone to reinfection, suggests first large-scale study of its kind. Read https://t.co/250Yv0a9BZ pic.twitter.com/BTjhcMzXwT
— The Lancet (@TheLancet) March 17, 2021
Five-year outcomes of PFO closure or antiplatelet therapy for cryptogenic stroke
17 Mar, 2021 | 02:40h | UTCPFO Closure for Stroke Is Safe, Effective at 5 Years: REDUCE – TCTMD
Original study: Five-Year Outcomes of PFO Closure or Antiplatelet Therapy for Cryptogenic Stroke – New England Journal of Medicine ($)
USPSTF Draft Statement: Start screening for Prediabetes and Type 2 Diabetes Mellitus in adults ages 35 to 70 years who are overweight or obese
17 Mar, 2021 | 02:41h | UTCCommentary: USPSTF Lowers Age for Diabetes Screening in Draft Recommendation – NEJM Journal Watch
UC secures landmark open access deal with world’s largest scientific publisher
17 Mar, 2021 | 02:33h | UTC
Commentary on Twitter
Good to see that the University of California and Elsevier has reached an agreement in which "all research with a UC lead author published in Elsevier’s extensive portfolio of hybrid and open access journals will be #openaccess by default"
— Robert Kiley (@robertkiley) March 16, 2021
RCT: No benefit from marine Omega-3 fatty acid and Vitamin D supplementation on incident atrial fibrillation
17 Mar, 2021 | 02:38h | UTCEffect of Marine Omega-3 Fatty Acid and Vitamin D Supplementation on Incident Atrial Fibrillation: A Randomized Clinical Trial – JAMA (free for a limited period)
Editorial: Omega-3 Fatty Acids and Atrial Fibrillation – JAMA (free for a limited period)
Opinion | Cardiovascular harm from egg yolk and meat: More than just cholesterol and saturated fat
17 Mar, 2021 | 02:35h | UTC
Systematic review | Hospital at home: home‐based end‐of‐life care
17 Mar, 2021 | 02:31h | UTCHospital at home: home‐based end‐of‐life care – Cochrane Library
Summary: Home-based end-of-life care – Cochrane Library
Consensus Document: Management of acute myocarditis and chronic inflammatory cardiomyopathy
17 Mar, 2021 | 02:28h | UTC
Systematic review: Interventions for cutaneous disease in systemic lupus erythematosus
17 Mar, 2021 | 02:30h | UTCInterventions for cutaneous disease in systemic lupus erythematosus – Cochrane Library
Podcast | Abdominal pain: Physical exam series
17 Mar, 2021 | 02:25h | UTC#261, #262 Abdominal Pain: Physical Exam Series – The Curbsiders Internal Medicine Podcast
A randomized, noninferiority, controlled trial of two doses of intravenous subdissociative ketamine for analgesia in the emergency department
17 Mar, 2021 | 02:13h | UTCA randomized, noninferiority, controlled trial of two doses of intravenous subdissociative ketamine for analgesia in the emergency department – Academic Emergency Medicine (link to abstract – $ for full-text)
Commentaries: Lower dose of ketamine is as effective as the standard dose to treat pain in adults – Loyola University Health System AND Lower doses of ketamine shown to be non-inferior for acute pain control in the emergency setting – 2 Minute Medicine
M-A: Time to reconsider the routine use of tourniquets in total knee arthroplasty surgery
17 Mar, 2021 | 02:23h | UTC
[Preprint] Delaying second vaccine dose leaves cancer patients vulnerable to virus
17 Mar, 2021 | 02:58h | UTCNews release: Delaying second vaccine dose leaves cancer patients vulnerable to virus – King’s College London
Commentaries: Expert reaction to preprint looking at antibody immune response following one dose of Pfizer COVID-19 vaccine in cancer patients – Science Media Centre AND Cancer patients ‘lack same protection’ after first jab – BBC
WHO points to wildlife farms in southern China as likely source of pandemic
17 Mar, 2021 | 03:02h | UTCWHO Points To Wildlife Farms In Southern China As Likely Source Of Pandemic – wbur
WHO: New research highlights risks of separating newborns from mothers during COVID-19 pandemic
17 Mar, 2021 | 03:04h | UTC
Immunogenicity of a single dose of SARS-CoV-2 mRNA vaccine in solid organ transplant recipients
17 Mar, 2021 | 02:55h | UTC